Atlas Trials

A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma

Clinical trial NCT06748053 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06748053
Sponsor
GlaxoSmithKline
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2025-02-10
Primary completion
2026-07-14
Enrollment
307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.